Chicago Partners Investment Group LLC Exelixis, Inc. Transaction History

Chicago Partners Investment Group LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 11, 2019	SELL	$13.65 - $21.8 $44,294 - $70,741	-3,245 Closed	0 $0
Q3 2018 Nov 05, 2018	BUY	$15.87 - $22.4 $19,044 - $26,880	1,200 Added 58.68%	3,245 $44,000
Q2 2018 Aug 31, 2018	BUY	$18.56 - $22.45 $17,539 - $21,215	945 Added 85.91%	2,045 $44,000
Q4 2017 Mar 28, 2018	BUY	$24.23 - $30.93 $26,653 - $34,023	1,100	1,100 $0

501

244M

2.54M

2.29M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.5B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of Chicago Partners Investment Group LLC, based on Form 13F filings with the SEC.

Stay updated on Chicago Partners Investment Group LLC with notifications on news.